CT25-201 - 1

Products Administration (NMPA), ensuring compliance with Chinese regulatory requirements.

To appoint a qualified local representative in China responsible for managing the registration process of a Drug Master File (DMF) for 2 Active Pharmaceutical Ingredients (API – Mo-99 and I-131) with the National Medical